A highly accomplished entrepreneur with 18+ years of experience in medical device, consumer, and technology industries. Based in US West Coast, Shilo has raised over $60M and built companies valued at hundreds of millions.
Entrepreneurial Portfolio
D-CURE
Non-profit advancing diabetes research
DARIO
Breakthrough platform for diabetes management
SMARTZYME
Advanced tools for protein engineering
MYBIOTICS
Microbiome pharmaceutical solutions
EMENDO
Gene editing tools for genetic disorders
EMULAIT
Revolutionizing infant feeding
Novo Vessel
mRNA based solutions
Core Skills & Expertise
Business Strategy
Identifying market gaps and developing innovative solutions that create significant value and impact.
Fundraising
Raised over $60M across multiple ventures from diverse investor groups.
Innovation
Multiple patents and award-winning products that transform industries.
Leadership
Building and leading world-class teams across medical, tech, and consumer sectors.
Career Highlights
Novo Vessel (2025-Present)
Co-founded mRNA based solutions to promote blood vessel formation in the body. Raised $3M+
Emulait (2021-Present)
Founded and serves as CEO of Emulait, developing the world's first biomimetic baby bottle that emulates breastfeeding. Raised $24M in funding.
Emendo Biotherapeutics (2016-2020)
Co-founded gene editing company acquired by AnGes for $300 million.
DarioHealth (2008-2014)
Co-founded and led LabStyle Innovations (DarioHealth), creating the first smart glucose meter with mobile connectivity. Raised $40M+.
Smartzyme (2014-2017)
Developed advanced tools for protein engineering.
MyBiotics (2017-)
Developed Microbiome pharmaceutical solutions
Emulait: Revolutionizing Infant Feeding
Personal Inspiration
His daughter's breastfeeding challenges inspired him to create an infant feeding solution for families worldwide.
Innovative Technology
Developed a patent-protected infant feeding system which closes the gap between breast and bottle for the healthiest and most natural feed, and personalizes the bottle feeding experience.
Market Impact
Poised to disrupt the high-value parenting market with innovative design thinking. biomimetic scanning technology and strong retail partnerships.
DarioHealth: Pioneering Mobile Health
Innovation
Created the first smart glucose meter connecting to mobile devices through a diabetes management app.
Growth
Raised over $40M in funding, driving rapid expansion and technology development.
Success
Achieved public listing with peak valuation of $300-400 million, revolutionizing diabetes management.
Recognition & Awards
Shilo's innovations have received prestigious accolades, including Time Magazine's 2024 Best Inventions recognition and JPMA's Best Feeding Innovation award.
Contact & Connect
Self-taught entrepreneur with 18+ years of experience across medical device, consumer, and technology industries.
Diabetes advocacy, maternal health, technology innovation, social impact, and mentoring emerging entrepreneurs.
Active supporter of various non-profit organizations focused on diabetes research, maternal health, and child welfare.
Shilo Ben Zeev: Serial Entrepreneur | Innovator | Investor